Literature DB >> 19329883

Semaphorin signals on the road to cancer invasion and metastasis.

Sabrina Rizzolio1, Luca Tamagnone.   

Abstract

Semaphorins are a large family of secreted and membrane-bound molecules initially implicated in the development of the nervous system and in axon guidance. More recently, they have been found to regulate cell adhesion and cell motility, angiogenesis, immune function and tumour progression. Notably, Semaphorins have been implicated with opposite functions in cancer: either as putative tumor suppressors and anti-angiogenic factors, or as mediating tumour angiogenesis, invasion and metastasis. Interestingly, Semaphorins may display divergent activities in different cell types. These multifaceted functions may be explained by the involvement of different kinds of semaphorin receptor complexes, and by the consequent activation of multiple signaling pathways, in different cells or different functional stages. Semaphorin signaling is largely mediated by the Plexins. However, semaphorin receptor complexes may also include Neuropilins and tyrosine kinases implicated in cancer. In this review, we will focus on major open questions concerning the potential role of Semaphorin signals in cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19329883      PMCID: PMC2633973          DOI: 10.4161/cam.1.2.4570

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  115 in total

Review 1.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

2.  Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2.

Authors:  Toshihiko Toyofuku; Hong Zhang; Atsushi Kumanogoh; Noriko Takegahara; Fumikazu Suto; Junko Kamei; Kazuhiro Aoki; Masanori Yabuki; Masatsugu Hori; Hajime Fujisawa; Hitoshi Kikutani
Journal:  Genes Dev       Date:  2004-02-20       Impact factor: 11.361

3.  Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.

Authors:  Eduard Batlle; Jeffrey T Henderson; Harry Beghtel; Maaike M W van den Born; Elena Sancho; Gerwin Huls; Jan Meeldijk; Jennifer Robertson; Marc van de Wetering; Tony Pawson; Hans Clevers
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

4.  In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.

Authors:  Gunter Schuch; Marcelle Machluf; Georg Bartsch; Masashi Nomi; Henri Richard; Anthony Atala; Shay Soker
Journal:  Blood       Date:  2002-12-15       Impact factor: 22.113

5.  Identification of two novel alternatively spliced Neuropilin-1 isoforms.

Authors:  Frank C Cackowski; Li Xu; Bo Hu; Shi-Yuan Cheng
Journal:  Genomics       Date:  2004-07       Impact factor: 5.736

6.  The human semaphorin 6B gene is down regulated by PPARs.

Authors:  Philippe Collet; Lionel Domenjoud; Marie Dominique Devignes; Hossam Murad; Hervé Schohn; Michel Dauça
Journal:  Genomics       Date:  2004-06       Impact factor: 5.736

7.  Plexin-B3 is a functional receptor for semaphorin 5A.

Authors:  Stefania Artigiani; Paolo Conrotto; Pietro Fazzari; Giorgio F Gilestro; Davide Barberis; Silvia Giordano; Paolo M Comoglio; Luca Tamagnone
Journal:  EMBO Rep       Date:  2004-06-25       Impact factor: 8.807

8.  Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.

Authors:  Mitsuharu Fukasawa; Murray Korc
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531

9.  Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.

Authors:  Alexander A Parikh; Fan Fan; Wen Biao Liu; Syed A Ahmad; Oliver Stoeltzing; Niels Reinmuth; Diane Bielenberg; Corazon D Bucana; Michael Klagsbrun; Lee M Ellis
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.

Authors:  Jakub M Swiercz; Rohini Kuner; Stefan Offermanns
Journal:  J Cell Biol       Date:  2004-06-21       Impact factor: 10.539

View more
  13 in total

Review 1.  Semaphorin 5A mediated cellular navigation: connecting nervous system and cancer.

Authors:  Abhilasha Purohit; Anguraj Sadanandam; Pavan Myneni; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2014-09-28

2.  The intervention of valproic acid on the tumorigenesis induced by an environmental carcinogen of PAHs.

Authors:  Junxuan Peng; Zuchao Cai; Ruixue Zhao; Jiahao Chen; Guochao Liu; Chao Dong; David Lim; Zhihui Feng
Journal:  Toxicol Res (Camb)       Date:  2020-08-31       Impact factor: 3.524

3.  Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.

Authors:  Asha Balakrishnan; Junia Y Penachioni; Simona Lamba; Fonnet E Bleeker; Carlo Zanon; Monica Rodolfo; Viviana Vallacchi; Aldo Scarpa; Lara Felicioni; Matthias Buck; Antonio Marchetti; Paolo M Comoglio; Alberto Bardelli; Luca Tamagnone
Journal:  Hum Mutat       Date:  2009-08       Impact factor: 4.878

4.  Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma.

Authors:  Maoran Li; Danhua Xu; Xiang Xia; Bo Ni; Chunchao Zhu; Gang Zhao; Hui Cao
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

5.  Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.

Authors:  Shuai Chen; Yi Wei; Hanyang Liu; Yu Gong; Yan Zhou; Haojun Yang; Liming Tang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.

Authors:  Yuji Yoshida; Atsushi Ogata; Sujin Kang; Kousuke Ebina; Kenrin Shi; Satoshi Nojima; Tetsuya Kimura; Daisuke Ito; Keiko Morimoto; Masayuki Nishide; Takashi Hosokawa; Toru Hirano; Yoshihito Shima; Masashi Narazaki; Hideki Tsuboi; Yukihiko Saeki; Tetsuya Tomita; Toshio Tanaka; Atsushi Kumanogoh
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

7.  Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis.

Authors:  Sugandha Saxena; Yuri Hayashi; Lingyun Wu; Mohammad Awaji; Pranita Atri; Michelle L Varney; Abhilasha Purohit; Satyanarayana Rachagani; Surinder K Batra; Rakesh K Singh
Journal:  Oncotarget       Date:  2017-12-23

Review 8.  MICAL, the flavoenzyme participating in cytoskeleton dynamics.

Authors:  Maria A Vanoni; Teresa Vitali; Daniela Zucchini
Journal:  Int J Mol Sci       Date:  2013-03-27       Impact factor: 5.923

9.  Role of the nervous system in cancer metastasis.

Authors:  Sha Li; Yanlai Sun; Dongwei Gao
Journal:  Oncol Lett       Date:  2013-01-31       Impact factor: 2.967

10.  Silencing of semaphorin 3C suppresses cell proliferation and migration in MCF-7 breast cancer cells.

Authors:  Xiaofang Zhu; Xiangjian Zhang; Zhiqiang Ye; Yizuo Chen; Lin Lv; Xiaohua Zhang; Hongye Hu
Journal:  Oncol Lett       Date:  2017-09-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.